Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hamre

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Genetics and Molecular Research : GMR|December 17, 2013
Critical evaluation of transcription factor Atf2 as a candidate modulator of alcohol preference in mouse and human populationsL S Wang, Y Jiao, Y Huang, et al.
British Journal of Cancer|February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancerAnne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Oncoimmunology|July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockadeAnne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Genetics and Molecular Research : GMR|December 17, 2013
Critical evaluation of transcription factor Atf2 as a candidate modulator of alcohol preference in mouse and human populationsL S Wang, Y Jiao, Y Huang, et al.
British Journal of Cancer|February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancerAnne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Oncoimmunology|July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockadeAnne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Pageof 6